| 引用本文：高立群, 马继炎, 杨明芳, 李贤哲, 刘光奇, 黄旸木.突发公共卫生事件下世界卫生组织推动全球医药产品创新与可及的行动[J].中国卫生政策研究,2021,14(1):66-73 |
|
| 突发公共卫生事件下世界卫生组织推动全球医药产品创新与可及的行动 |
| 投稿时间：2020-08-28 修订日期：2021-01-08 PDF全文浏览 HTML全文浏览 |
| 高立群, 马继炎, 杨明芳, 李贤哲, 刘光奇, 黄旸木 |
| 北京大学公共卫生学院 北京 100191 |
| 摘要:全球医药产品创新与可及是推动全球健康公平、维护全球卫生安全的重要内容，更是有效防控传染病暴发流行等突发公共卫生事件的关键手段。世界卫生组织（WHO）作为全球最大的政府间卫生组织，在多次抗击突发公共卫生事件中制定了系列政策和行动方案。本文总结了WHO在全球医药产品创新与可及领域所采取的行动，如制定研发蓝图、推动紧急使用清单程序等，并以新型冠状病毒肺炎（COVID-19）疫情为案例，介绍了WHO在该突发公共卫生事件下的行动。同时，提出建立全球生物样本与惠益共享机制、促进医药产品研发合作、加强协调和监管全球及区域医药产品生产供应等建议，为中国更好地参与推动全球医药创新和可及提供论证支持。 |
| 关键词:世界卫生组织 突发公共卫生事件 医药创新与可及 新型冠状病毒肺炎 |
| 基金项目:国家知识产权局软科学研究项目（SS20-B-12）；国家自然科学基金面上项目（72074009） |
|
| WHO's initiatives to promote global pharmaceutical innovation and access under public health emergencies |
| GAO Li-qun, MA Ji-yan, YANG Ming-fang, LI Xian-zhe, LIU Guang-qi, HUANG Yang-mu |
| School of Public Health, Peking University, Beijing 100191, China |
| Abstract:Global pharmaceutical innovation and access plays a crucial role in achieving global health equity and maintaining global health security. It is also a vital means to effectively prevent and control outbreaks of infectious diseases and other public health emergencies. As the world's largest intergovernmental health organization, the World Health Organization (WHO) has formulated a series of policies and action plans to fight against global public health emergencies. This paper summarizes the initiatives taken by the WHO for promoting global pharmaceutical innovation and access, such as formulating the WHO R&D Blueprint and developing the WHO Emergency Use Listing Procedure (EUL). It exemplifies how the WHO has responded to support access to medicines during the COVID-19 pandemic. This paper puts forward suggestions concerning the establishment of a global biological sample and benefit-sharing mechanism, enhancing strategic alliance in pharmaceutical R&D, and strengthen coordination and regulation in global and regional pharmaceutical production and supply chains. It provides demonstration support on how China can better participate in driving global pharmaceutical innovation and access to medicines. |
| Key words:World Health Organization Public health emergencies Pharmaceutical innovation and access COVID-19 |
| 摘要点击次数: 2158 全文下载次数: 960 |
|
|
